Kite Pharma, Inc. Contracts & Agreements
58 Contracts & Agreements
- Business Finance (12 contracts)
- Business Operations (9)
- Human Resources (12)
- Intellectual Property (7)
- Mergers & Acquisitions (1)
- Real Estate (5)
- Uncategorized (12)
- Form of Excise Tax Reimbursement Payment Letter Agreement (Filed With SEC on September 5, 2017)
- AGREEMENT AND PLAN OF MERGER among: KITE PHARMA, INC., a Delaware corporation; GILEAD SCIENCES, INC., aDelaware corporation; and DODGERS MERGER SUB, INC., a Delaware corporation... (Filed With SEC on August 28, 2017)
- COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on May 8, 2017)
- 4,750,000Shares of Common Stock Kite Pharma, Inc. UNDERWRITING AGREEMENT (Filed With SEC on March 6, 2017)
- KITE PHARMA, INC. STOCK OPTION GRANT NOTICE (2014 EQUITY INCENTIVE PLAN) (Filed With SEC on February 28, 2017)
- KITE PHARMA, INC. (2014 EQUITY INCENTIVE PLAN) NOTICE OF GRANT (Filed With SEC on February 28, 2017)
- KITE PHARMA, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY ADOPTED: JUNE 6, 2014 AMENDED: DECEMBER 17, 2015, DECEMBER 12, 2016 AND JANUARY 3, 2017 (Filed With SEC on February 28, 2017)
- 2225 Colorado Avenue Santa Monica, CA 90404 Phone ###-###-#### Fax ###-###-#### www.kitepharma.com (Filed With SEC on August 8, 2016)
- RESEARCH COLLABORATION AND LICENSE AGREEMENT by and between AMGEN INC. and KITE PHARMA, INC. Dated as of December 31, 2014 (Filed With SEC on August 8, 2016)
- RESEARCH COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on August 8, 2016)
- AIR COMMERCIAL REAL ESTATE ASSOCIATION STANDARD INDUSTRIAL/COMMERCIAL MULTI-TENANT LEASE - NET (Filed With SEC on July 6, 2016)
- 2225 Colorado Avenue Santa Monica, CA 90404 Phone ###-###-#### Fax ###-###-#### www.kitepharma.com (Filed With SEC on May 9, 2016)
- National Institutes of Health SECOND AMENDMENT TO L-068-2013/0 (Filed With SEC on May 9, 2016)
- National Institutes of Health SECOND AMENDMENT TO L ###-###-####/0 (Filed With SEC on May 9, 2016)
- National Institutes of Health SECOND AMENDMENT TO L-077-2015/0 (Filed With SEC on May 9, 2016)
- National Institutes of Health FIRST AMENDMENT TO L-002-2016/0 (Filed With SEC on May 9, 2016)
- KITE PHARMA, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY ADOPTED: JUNE 6, 2014 AMENDED: DECEMBER 17, 2015 (Filed With SEC on February 29, 2016)
- Kite Pharma, Inc. Change in Control and Severance Benefit Plan Approved by the Board of Directors: December 17, 2015 (Filed With SEC on February 29, 2016)
- EXHIBIT A Proprietary Information and Invention Assignment Agreement (Filed With SEC on February 29, 2016)
- National Institutes of Health FIRST AMENDMENT TO L-068-2013/0 (Filed With SEC on February 29, 2016)
- National Institutes of Health FIRST AMENDMENT TO L ###-###-####/0 (Filed With SEC on February 29, 2016)
- THE NATIONAL INSTITUTES OF HEALTH PATENT LICENSE AGREEMENT EXCLUSIVE COVER PAGE (Filed With SEC on February 29, 2016)
- License and research AGREEMENT (Filed With SEC on February 29, 2016)
- 3,625,000 Shares of Common Stock Kite Pharma, Inc. UNDERWRITING AGREEMENT (Filed With SEC on December 11, 2015)
- PUBLIC HEALTH SERVICE COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENT FOR INTRAMURAL-PHS CLINICAL RESEARCH (Filed With SEC on August 10, 2015)
- Amendment #1 Cooperative Research and Development Agreement # 02716 Cooperative Research and Development Agreement for the Development of NCI Proprietary Peripheral Blood... (Filed With SEC on August 10, 2015)
- National Institutes of Health FIRST AMENDMENT TO L-077-2015/0 (Filed With SEC on August 10, 2015)
- Amendment #1 Cooperative Research and Development Agreement # 02716 Cooperative Research and Development Agreement for the Development of NCI Proprietary Peripheral Blood... (Filed With SEC on May 15, 2015)
- AIR COMMERCIAL REAL ESTATE ASSOCIATION STANDARD INDUSTRIAL/COMMERCIAL SINGLE-TENANT LEASE -- NET (DO NOT USE THIS FORM FOR MULTI-TENANT BUILDINGS) (Filed With SEC on May 15, 2015)
- FIRST AMENDMENT TO STANDARD INDUSTRIAL/COMMERCIAL SINGLE-TENANT LEASE - NET (Filed With SEC on May 15, 2015)
- AIR COMMERCIAL REAL ESTATE ASSOCIATION STANDARD INDUSTRIAL/COMMERCIAL SINGLE-TENANT LEASE NET (DO NOT USE THIS FORM FOR MULTI-TENANT BUILDINGS) (Filed With SEC on May 15, 2015)
- RESEARCH COLLABORATION AND LICENSE AGREEMENT by and between AMGEN INC. and KITE PHARMA, INC. Dated as of December 31, 2014 (Filed With SEC on March 26, 2015)
- THE NATIONAL INSTITUTES OF HEALTH PATENT LICENSE AGREEMENT EXCLUSIVE COVER PAGE (Filed With SEC on March 26, 2015)
- [] Shares of Common Stock Kite Pharma, Inc. UNDERWRITING AGREEMENT (Filed With SEC on December 9, 2014)
- [] Kite Pharma, Inc. UNDERWRITING AGREEMENT (Filed With SEC on June 17, 2014)
- LICENSE AGREEMENT (Filed With SEC on June 17, 2014)
- THE NATIONAL INSTITUTES OF HEALTH PATENT LICENSE AGREEMENT EXCLUSIVE COVER PAGE (Filed With SEC on June 17, 2014)
- INDEMNITY AGREEMENT (Filed With SEC on June 11, 2014)
- KITE PHARMA, INC. 2014EQUITY INCENTIVE PLAN SECTION 1. DEFINITIONS (Filed With SEC on June 11, 2014)
- KITE PHARMA, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY ADOPTED: JUNE 6, 2014 (Filed With SEC on June 11, 2014)
- SEVERANCE AGREEMENT (Filed With SEC on June 11, 2014)
- CONSULTING AGREEMENT (Filed With SEC on June 11, 2014)
- EMPLOYMENT AGREEMENT (Filed With SEC on June 11, 2014)
- EMPLOYMENTAGREEMENT (Filed With SEC on June 11, 2014)
- EMPLOYMENT AGREEMENT (Filed With SEC on June 11, 2014)
- EMPLOYMENT AGREEMENT (Filed With SEC on June 11, 2014)
- KITE PHARMA, INC. AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Filed With SEC on May 19, 2014)
- SERVICES AGREEMENT (Filed With SEC on May 19, 2014)
- AIR COMMERCIAL REAL ESTATE ASSOCIATION STANDARD INDUSTRIAL/COMMERCIAL SINGLE-TENANT LEASE -- NET (DO NOT USE THIS FORM FOR MULTI-TENANT BUILDINGS) (Filed With SEC on May 19, 2014)
- LICENSE AGREEMENT (Filed With SEC on May 19, 2014)
- THE NATIONAL INSTITUTES OF HEALTH PATENT LICENSE AGREEMENT EXCLUSIVE/CO-EXCLUSIVE COVER PAGE (Filed With SEC on May 19, 2014)
- PUBLIC HEALTH SERVICE COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENT FOR INTRAMURAL-PHS CLINICAL RESEARCH (Filed With SEC on May 19, 2014)
- KITE PHARMA, INC. CONVERTIBLE PREFERRED STOCK/COMMON STOCK PURCHASE WARRANT (PLACEMENT AGENT WARRANT) (Filed With SEC on May 19, 2014)
- KITE PHARMA, INC. CONVERTIBLE PREFERRED STOCK/COMMON STOCK PURCHASE WARRANT (PLACEMENT AGENT WARRANT) (Filed With SEC on May 19, 2014)
- KITE PHARMA, INC. CONVERTIBLE PREFERRED STOCK/COMMON STOCK PURCHASE WARRANT (PLACEMENT AGENT WARRANT) (Filed With SEC on May 19, 2014)
- KITE PHARMA, INC. CONVERTIBLE PREFERRED STOCK/COMMON STOCK PURCHASE WARRANT (PLACEMENT AGENT WARRANT) (Filed With SEC on May 19, 2014)
- KITE PHARMA, INC. CONVERTIBLE PREFERRED STOCK/COMMON STOCK PURCHASE WARRANT (PLACEMENT AGENT WARRANT) (Filed With SEC on May 19, 2014)
- KITE PHARMA, INC. CONVERTIBLE PREFERRED STOCK/COMMON STOCK PURCHASE WARRANT (PLACEMENT AGENT WARRANT) (Filed With SEC on May 19, 2014)